Under construction – not a live service

Skip to content

Frontlight Research

Trial site

TREAD Research (Site 0354)

Cape Town, Western Cape 7500, South AfricaNot linked to an institution yet

1running trial

Running trials

Active, not recruiting
Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)
NCT04708041· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – TREAD Research (Site 0354): trial site – Frontlight Research